Abstract
To the Editor: In 2020, the Joint Commission reported that wrong-site surgery accounted for 8.6% of all sentinel events in medicine.1 In dermatology practices, wrong-site surgery is the most commonly reported severe error.2 High-quality biopsy-site photography is recognized as the gold standard for preoperative site identification in skin surgery.3,4 Herein, we describe BLSi (Better Lesional Site identification; pronounced “bullseye”), a quality improvement (QI) project to increase the rate of high-quality biopsy-site photographs and show how QI methodology, including rigorous measurement, can be successfully used to address this performance gap in a large academic dermatology department.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
